Benefits
Healthy Blood Sugar Levels
Chromium is component of glucose tolerance factor (GTF) — supports insulin function. Multiple trials of ChromeMate show modest improvements in fasting glucose, HbA1c, and glucose tolerance.
Lipid Profile Support
ChromeMate trials show modest reductions in total cholesterol and LDL cholesterol, with HDL increases in some studies.
Weight Management Adjunct
Chromium supports normal glucose handling which may help reduce sugar cravings and support weight management. Modest weight effects in trials.
Insulin Sensitivity
Chromium is essential for insulin function; supplementation may improve insulin sensitivity in deficient or insulin-resistant individuals.
Niacin-Bound Form Distinction
Niacin (vitamin B3) chelation distinguishes from chromium picolinate; provides chromium with cofactor support; some evidence for improved bioavailability.
Mechanism of action
Glucose Tolerance Factor (GTF) Component
Chromium is essential component of GTF — endogenous insulin-enhancing factor in human body. Adequate chromium supports insulin signaling.
Insulin Receptor Sensitivity
Chromium enhances insulin receptor activity and signaling; mechanism for blood sugar effects.
Niacin Cofactor Activity
Niacin (B3) component contributes additional metabolic effects — niacin itself has documented lipid effects (especially HDL increase) at high doses.
Niacin-Chromium Synergy
Niacin-bound form may offer synergistic effects on lipid metabolism and glucose handling vs chromium alone.
Clinical trials
Multiple ChromeMate clinical studies on glucose, insulin, and lipid markers.
Adults with metabolic concerns including type 2 diabetes adjunct.
Modest improvements in glucose handling, insulin sensitivity, and lipid markers.
Multiple chromium supplementation trials in glucose intolerance and type 2 diabetes.
Various populations.
Modest glucose handling improvements; effect size variable; bioavailable forms more reliable.
About this ingredient
CHROMEMATE® is a NIACIN-BOUND CHROMIUM COMPLEX (chromium polynicotinate) developed by LONZA — distinguished from chromium picolinate (the other widely-used chromium form) by NIACIN (VITAMIN B3) chelation. CHROMIUM BACKGROUND: trace mineral essential for normal glucose metabolism via glucose tolerance factor (GTF); chromium status declines with age and high-sugar diets; deficiency impairs insulin function.
KEY DISTINCTIONS: (1) NIACIN-BOUND form (chromium polynicotinate) — distinct from chromium picolinate; (2) Niacin cofactor support; (3) Multiple clinical trials; (4) Lonza pharmaceutical-grade quality.
EVIDENCE-BASED USES: (1) Healthy blood sugar levels; (2) Lipid profile (modest); (3) Weight management adjunct; (4) Insulin sensitivity; (5) Foundation chromium form for metabolic supplements.
CRITICAL CAUTIONS: (1) DIAGNOSED DIABETES — chromium is adjunct to medical management, not replacement; consult endocrinologist; monitor glucose closely; (2) DOSE — 200-400 mcg elemental chromium typical; AI 35 mcg/day (men), 25 mcg/day (women); supplement doses higher; (3) DIABETES MEDICATIONS — additive hypoglycemic effects; monitor; (4) PREGNANCY/LACTATION — RDA-level safe; therapeutic doses limited specific data; (5) CHROMEMATE vs CHROMIUM PICOLINATE — both common forms; some evidence ChromeMate has bioavailability advantage; both used; (6) CHROMIUM EVIDENCE OVERVIEW — modest effects on glucose management; not magic for diabetes; lifestyle (diet, exercise, weight) foundational; (7) FOR HYPOGLYCEMIA TENDENCY — chromium may help but excessive may worsen; monitor; (8) METABOLIC SYNDROME COMPONENT — chromium reasonable component alongside diet, exercise, possibly other supplements; (9) BRAND VERIFICATION — ChromeMate® is Lonza trademark (originally InterHealth, acquired by Lonza); specific clinical evidence on this branded form; (10) For COMPREHENSIVE METABOLIC HEALTH — diet (especially carbohydrate quality), exercise, weight management, sleep, stress management foundational; supplements adjunct.